Mapping dopaminergic projections in the human brain with resting-state fMRI. 2022

Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands.

The striatum receives dense dopaminergic projections, making it a key region of the dopaminergic system. Its dysfunction has been implicated in various conditions including Parkinson's disease (PD) and substance use disorder. However, the investigation of dopamine-specific functioning in humans is problematic as current MRI approaches are unable to differentiate between dopaminergic and other projections. Here, we demonstrate that 'connectopic mapping' - a novel approach for characterizing fine-grained, overlapping modes of functional connectivity - can be used to map dopaminergic projections in striatum. We applied connectopic mapping to resting-state functional MRI data of the Human Connectome Project (population cohort; N = 839) and selected the second-order striatal connectivity mode for further analyses. We first validated its specificity to dopaminergic projections by demonstrating a high spatial correlation (r = 0.884) with dopamine transporter availability - a marker of dopaminergic projections - derived from DaT SPECT scans of 209 healthy controls. Next, we obtained the subject-specific second-order modes from 20 controls and 39 PD patients scanned under placebo and under dopamine replacement therapy (L-DOPA), and show that our proposed dopaminergic marker tracks PD diagnosis, symptom severity, and sensitivity to L-DOPA. Finally, across 30 daily alcohol users and 38 daily smokers, we establish strong associations with self-reported alcohol and nicotine use. Our findings provide evidence that the second-order mode of functional connectivity in striatum maps onto dopaminergic projections, tracks inter-individual differences in PD symptom severity and L-DOPA sensitivity, and exhibits strong associations with levels of nicotine and alcohol use, thereby offering a new biomarker for dopamine-related (dys)function in the human brain.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009434 Neural Pathways Neural tracts connecting one part of the nervous system with another. Neural Interconnections,Interconnection, Neural,Interconnections, Neural,Neural Interconnection,Neural Pathway,Pathway, Neural,Pathways, Neural
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females

Related Publications

Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
April 2024, ArXiv,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
April 2018, NeuroImage,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
June 2023, NPJ digital medicine,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
August 2014, NeuroImage,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
March 2016, Human brain mapping,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
May 2008, NeuroImage,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
December 2013, NeuroImage,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
February 2012, NeuroImage,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
May 2017, AJNR. American journal of neuroradiology,
Marianne Oldehinkel, and Alberto Llera, and Myrthe Faber, and Ismael Huertas, and Jan K Buitelaar, and Bastiaan R Bloem, and Andre F Marquand, and Rick C Helmich, and Koen V Haak, and Christian F Beckmann
July 2022, Journal of neuroscience methods,
Copied contents to your clipboard!